Abstract
This report provides the reader with a comprehensive analysis of the domestic
and international markets involving pharmaceuticals to treat skin diseases and
disorders. This edition of Worldwide Market for Prescription Dermatologic
Drugs is the fifth time Kalorama Information has comprehensively studied the
dermatology markets.
As is the case with each new edition, Kalorama completely re-evaluated the
market from the ground up, and in addition to the usual primary interviewing
of industry participants, clinicians, and regulators, we also conducted scores
of interviews with users of Kalorama's 2002 and 2004 dermatological studies to
ensure that the current report contains the best possible data and the most
useful analysis.
Market information is available for the years 2000 to 2010, with the focus
year 2005 for competitive analysis. Overview and product descriptions of
general therapy segments are covered, including prescription drugs to treat:
- Acne and Rosacea
- Antiaging and Photodamage
- Dermatitis and Seborrhea
- Fungal Infections
- Hair Loss and Hair Removal
- Hyperpigmentation/Melasma
- Psoriasis
- Skin Cancer, and
- Other Skin Disorders
Other data points include competitive market share, demographics,
epidemiology, and geographic break down, which provide revenues for four
regions:
- United States
- Europe
- Japan
- Rest of world
The study covers issues and trends affecting the market, research and
developments, and more. In particular, the study explores the current and
potential effects of the aging baby boomers on the prescription dermatology
market and the continued demand for lifestyle drugs. Profiles of major market
participants are included.
View Cart
